A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Chronic Intractable Pain

In brief

The purpose of this study is to determine the safety and minimum effective dose of intraspinal gabapentin when delivered through an implanted drug infusion system.

Key facts

Study ID
NCT00414466
Run by
MedtronicNeuro
People needed
254
Starts
2006-12-01
Expected to finish
2010-08-01
Last updated by the study team
2013-08-23

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.